These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 24365061

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study.
    Lee YC, Cui J, Lu B, Frits ML, Iannaccone CK, Shadick NA, Weinblatt ME, Solomon DH.
    Arthritis Res Ther; 2011 Jun 08; 13(3):R83. PubMed ID: 21651807
    [Abstract] [Full Text] [Related]

  • 3. The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.
    Tanaka Y, Smolen JS, Jones H, Szumski A, Marshall L, Emery P.
    Arthritis Res Ther; 2019 Jul 05; 21(1):164. PubMed ID: 31277720
    [Abstract] [Full Text] [Related]

  • 4. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
    Chandrashekara S, Priyanka BU.
    Int J Rheum Dis; 2013 Jun 05; 16(3):291-6. PubMed ID: 23981750
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
    Wechalekar MD, Lester S, Proudman SM, Cleland LG, Whittle SL, Rischmueller M, Hill CL.
    Arthritis Rheum; 2012 May 05; 64(5):1316-22. PubMed ID: 22135142
    [Abstract] [Full Text] [Related]

  • 7. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.
    Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J, Aletaha D, van Riel PL.
    Ann Rheum Dis; 2009 Jun 05; 68(6):954-60. PubMed ID: 18490431
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y, Youssef SS, El Gaafary M.
    J Rheumatol; 2006 Mar 05; 33(3):490-7. PubMed ID: 16511918
    [Abstract] [Full Text] [Related]

  • 11. Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis.
    Thiele K, Huscher D, Bischoff S, Späthling-Mestekemper S, Backhaus M, Aringer M, Kohlmann T, Zink A, German Collaborative Arthritis Centres.
    Ann Rheum Dis; 2013 Jul 05; 72(7):1194-9. PubMed ID: 22915625
    [Abstract] [Full Text] [Related]

  • 12. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
    Matsui T, Kuga Y, Kaneko A, Nishino J, Eto Y, Chiba N, Yasuda M, Saisho K, Shimada K, Tohma S.
    Ann Rheum Dis; 2007 Sep 05; 66(9):1221-6. PubMed ID: 17369281
    [Abstract] [Full Text] [Related]

  • 13. Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission.
    Aletaha D, Wang X, Zhong S, Florentinus S, Monastiriakos K, Smolen JS.
    Semin Arthritis Rheum; 2020 Apr 05; 50(2):276-284. PubMed ID: 31590930
    [Abstract] [Full Text] [Related]

  • 14. The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    de Punder YM, Fransen J, Kievit W, Houtman PM, Visser H, van de Laar MA, van Riel PL.
    Rheumatology (Oxford); 2012 Sep 05; 51(9):1610-7. PubMed ID: 22539487
    [Abstract] [Full Text] [Related]

  • 15. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.
    Castrejón I, Dougados M, Combe B, Guillemin F, Fautrel B, Pincus T.
    J Rheumatol; 2013 Apr 05; 40(4):386-93. PubMed ID: 23378463
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity.
    Krieckaert CL, Jamnitski A, Nurmohamed MT, Kostense PJ, Boers M, Wolbink G.
    Arthritis Rheum; 2012 Dec 05; 64(12):3850-5. PubMed ID: 22933315
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.